Thank you.
What I hear around the room—from the three of you—is that there's obviously an interest in creating this registry. I'm just putting that out there. Ultimately, I'm hearing there's value to that.
Dr. Greaves, you presented a PowerPoint presentation. It talked about things you looked at that would be required for a successful breast registry. I'll read them quickly: “Clear objectives; Stable long term funding; Independent—financially, technically, but responsive to stakeholders; Simple interface/data upload; Opt out; Concise data requirements; Clean data which can be utilized/reported easily”.
I'm pulling that up from one of those slides.
I want to focus on the opt-out aspect. We've heard from many of you about whether we should be opting out or opting in, and about the concerns we have about, number one, informed consent of the patient and, number two, privacy issues.
I'll start with Dr. Morris. Would you like to speak to that?